ArticleAnimal models and experimental medicine2026
Time-course characterization of intraocular pressure in murine steroid-induced ocular hypertension: Effects of route, schedule, and concentration.
Article in Animal models and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Intraocular pressure (IOP) is the only modifiable risk factor for glaucoma, making animal models of ocular hypertension (OHT) foundational for research. Steroid-induced OHT is a strong candidate model, yet published steroid models rarely provide quantitative guidance on how route, dose, and schedule shape the pressure-time course, leaving laboratories to pilot protocols and hindering cross-study comparisons. We examined an OHT model using depot dexamethasone acetate injections, and systematically characterized IOP profiles in C57BL/6J mice across two injection routes (subconjunctival or periorbital), two dosing schedules (3 doses/1 week; 5 doses/4 weeks), and two concentrations (20 μL, 10 or 20 mg/mL). Steroid exposure produced OHT in every treated mouse, occurring rapidly by day 2, peaking on days 27-31, and declining to baseline by day 98. Maximum IOP increased ~90%-100% above baseline (from ~11-12 mmHg to ~22-23 mmHg). Increasing the dosing regimen from three to five doses modestly raised mean IOP over the study period without changing maximum IOP and peak timing. Increasing dexamethasone concentration increased maximum and mean IOP, without prolonging the duration of IOP elevation. Subconjunctival and periorbital injections were performed similarly, with consistent responses across sexes and minimal diurnal variation. These results provide researchers with clear benchmarks for selecting steroid regimens, guide interpretation of therapeutic effects, and offer a reproducible, practical platform for glaucoma research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.